A high-sensitivity nucleic acid amplification test (NAAT/PCR) for COVID-19 detection with nasal swab or saliva samples. Achieves 98% sensitivity and 99% specificity with nasal swabs, meets CDC international travel requirements, and provides lab-quality results at point-of-care.
Manufactured by
United States
Aptitude Medical Systems Inc. manufactures the Metrix platform, a point-of-care molecular diagnostic system that simplifies DNA/RNA-based testing through microfluidics technology. The platform reduces unnecessary cost and complexity to enable healthcare providers to deliver high-quality diagnostics to patients while improving operational efficiency.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Triplex International Biosciences(China) Co.,LTD.
China · 1 relevant product
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 1 relevant product
Anbio Biotechnology Limited
Germany · 2 relevant products
86 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 115 closest product alternatives
Triplex International Biosciences(China) Co.,LTD. · China
A nucleic acid test kit for qualitative detection of SARS-CoV-2 (2019-nCoV) in vitro specimens. This diagnostic test kit utilizes PCR technology for accurate identification of COVID-19 infection.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
Rapid antigen test for SARS-CoV-2 detection using latex chromatography assay technology. Designed for self-testing via anterior nasal swab sampling with results available in minutes. Enables point-of-care COVID-19 screening in clinical and non-clinical settings.
Anbio Biotechnology Limited · Germany
Molecular diagnostic test for SARS-CoV-2 detection using RT-PCR methodology. Provides accurate identification of active COVID-19 infection in clinical specimens.
112 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products